Biotech

All Articles

BMS axes bispecific months after filing to operate stage 3 trial

.Bristol Myers Squibb has possessed a whiplash change of heart on its BCMA bispecific T-cell engager...

Charles Baum manages Terremoto as CEO

.Charles Baum, M.D., Ph.D., that oversaw Mirati Rehabs' $ 5.8 billion sale to Bristol Myers Squibb l...

Asarina to close after initiatives to partner Tourette's medication neglect

.After reaching out to much more than 200 companies to companion a Tourette disorder treatment that ...

Novartis pens $150M in advance bispecifics manage Dren Biography

.Novartis has actually possessed some misfortune with bispecific antibodies in the past, but evaluat...

AstraZeneca plants an EGFR tree with Pinetree package worth $45M

.Pinetree Therapeutics will definitely help AstraZeneca plant some trees in its pipe with a brand-ne...

GRO rounds up $60M series B to take gout arthritis treatment in to center

.GRO Biosciences has ended the full week with an extra $60.3 thousand in the financial institution, ...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava loses CEO

.Accept to recently's Chutes &amp Ladders, our roundup of considerable management hirings, firings a...